ConductScience.org, home

Paper19789364

Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression.

Hoque MO and 21 others. Cancer Epidemiol Biomarkers Prev, 2009. Cited by 65 papers, by iCite.

Cite this record

ConductScience Library. Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression. Papers, record 19789364. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19789364

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression.
PubMed
Journal
Cancer Epidemiol Biomarkers Prev
PubMed
Year
2009
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
65
iCite
Relative citation ratio, by iCite
1.48
iCite
Revised in PubMed
2021-10-20
PubMed

Authors22

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hoque MOMohammad Obaidul
2Prencipe MMaria
3Poeta MLMaria Luana
4Barbano RRaffaela
5Valori VMVanna Maria
6Copetti MMassimiliano
7Gallo APAntonietta Pia
8Brait MMariana
9Maiello EEvaristo
10Apicella AAdolfo
11Rossiello RRaffaele
12Zito FFrancesco
13Stefania TTommasi
14Paradiso AAngelo
15Carella MMassimo
16Dallapiccola BBruno
17Murgo RRoberto
18Carosi IIlluminato
19Bisceglia MMichele
20Fazio VMVito Michele

Source PubMed

See all 22 authorsDownload CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Carcinoma, Ductal, BreastMajor topic
CpG IslandsMajor topic
DNA MethylationMajor topic
Adult
Disease Progression
Female
Humans
Middle Aged
Polymerase Chain Reaction
Promoter Regions, Genetic

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P30 CA006973NCI NIH HHSUnited StatesP30CA006973PubMedNIH RePORTER
P50 CA098252NCI NIH HHSUnited StatesP50CA098252PubMed and NIHNIH RePORTER

Download CSV of grants

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112800196Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability.Int J Cancer2003https://conductscience.org/library/papers/12800196PubMed
22567800In-situ breast cancer: the EORTC consensus meeting.Lancet1989https://conductscience.org/library/papers/2567800PubMed
314580249The diagnosis and management of pre-invasive breast disease: genetic alterations in pre-invasive lesions.Breast Cancer Res2003https://conductscience.org/library/papers/14580249PubMed
47585573E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.Cancer Res1995https://conductscience.org/library/papers/7585573PubMed
58638126Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly.Science1996https://conductscience.org/library/papers/8638126PubMed
63742467Fine-needle aspiration of breast cancer. Relationship of clinical factors to cytology results in 689 primary malignancies.Cancer1986https://conductscience.org/library/papers/3742467PubMed
79496256Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.J Pathol1997https://conductscience.org/library/papers/9496256PubMed
88256859Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.Am J Pathol1993https://conductscience.org/library/papers/8256859PubMed
911717336Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma.J Natl Cancer Inst2001https://conductscience.org/library/papers/11717336PubMed
1014614048Methylation profiling of benign and malignant breast lesions and its application to cytopathology.Mod Pathol2003https://conductscience.org/library/papers/14614048PubMed
1112960130Detection of gene promoter hypermethylation in fine needle washings from breast lesions.Clin Cancer Res2003https://conductscience.org/library/papers/12960130PubMed
127781895Expression and functional role of E- and P-cadherins in mouse mammary ductal morphogenesis and growth.Dev Biol1995https://conductscience.org/library/papers/7781895PubMed
1311309270A gene hypermethylation profile of human cancer.Cancer Res2001https://conductscience.org/library/papers/11309270PubMed
1411602373Cancer burden in the year 2000. The global picture.Eur J Cancer2001https://conductscience.org/library/papers/11602373PubMed
1516007089Distinct epigenetic changes in the stromal cells of breast cancers.Nat Genet2005https://conductscience.org/library/papers/16007089PubMed
1610397238Allelotype of posterior uveal melanoma: implications for a bifurcated tumor progression pathway.Cancer Res1999https://conductscience.org/library/papers/10397238PubMed
1710655057Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.Nat Genet2000https://conductscience.org/library/papers/10655057PubMed
1810667580Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin.Cancer Res2000https://conductscience.org/library/papers/10667580PubMed
193677009Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study.Cancer1987https://conductscience.org/library/papers/3677009PubMed
209365159E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis.Br J Cancer1997https://conductscience.org/library/papers/9365159PubMed

See all 39 referencesDownload CSV of references

Cited by41

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 65 citations.

PMIDTitleJournalYearIn PapersSource
41751248The Complex Path from Mammary Ductal Hyperplasia to Breast Cancer: Elevated Malignancy Risk in Atypical Forms.Biomedicines2026https://conductscience.org/library/papers/41751248PubMed
40809180Ketone body, as an emerging modulator of metabolic reprogramming and epigenetics in breast cancer.Iran J Basic Med Sci2025https://conductscience.org/library/papers/40809180PubMed
39261937Genome-wide characterization of dynamic DNA 5-hydroxymethylcytosine and TET2-related DNA demethylation during breast tumorigenesis.Clin Epigenetics2024https://conductscience.org/library/papers/39261937PubMed
39138705E-cadherin staining in the diagnosis of lobular versus ductal neoplasms of the breast: the emperor has no clothes.Histopathology2025https://conductscience.org/library/papers/39138705PubMed
37881785Methylation of ESR1 promoter induced by SNAI2-DNMT3B complex promotes epithelial-mesenchymal transition and correlates with poor prognosis in ERα-positive breast cancers.MedComm (2020)2023https://conductscience.org/library/papers/37881785PubMed
30416383Paired box 5 is a novel marker of breast cancers that is frequently downregulated by methylation.Int J Biol Sci2018https://conductscience.org/library/papers/30416383PubMed
30306389Beyond DNA: the Role of Epigenetics in the Premalignant Progression of Breast Cancer.J Mammary Gland Biol Neoplasia2018https://conductscience.org/library/papers/30306389PubMed
29682089Large-scale analysis of DFNA5 methylation reveals its potential as biomarker for breast cancer.Clin Epigenetics2018https://conductscience.org/library/papers/29682089PubMed
28979331Study of the Role of siRNA Mediated Promoter Methylation in DNMT3B Knockdown and Alteration of Promoter Methylation of CDH1, GSTP1 Genes in MDA-MB -453 Cell Line.Iran J Pharm Res2017https://conductscience.org/library/papers/28979331PubMed
28403857Hypermethylation of CDKN2A exon 2 in tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients.BMC Cancer2017https://conductscience.org/library/papers/28403857PubMed
28186977Pathological complete response of HER2-positive breast cancer to trastuzumab and chemotherapy can be predicted by HSD17B4 methylation.Oncotarget2017https://conductscience.org/library/papers/28186977PubMed
27478702Association between aberrant APC promoter methylation and breast cancer pathogenesis: a meta-analysis of 35 observational studies.PeerJ2016https://conductscience.org/library/papers/27478702PubMed
27308263Quantitation of CDH1 promoter methylation in formalin-fixed paraffin-embedded tissues of breast cancer patients using differential high resolution melting analysis.Adv Biomed Res2016https://conductscience.org/library/papers/27308263PubMed
27191268Quantitative assessment of the association between APC promoter methylation and breast cancer.Oncotarget2016https://conductscience.org/library/papers/27191268PubMed
27065772DNA methylation assessment as a prognostic factor in invasive breast cancer using methylation-specific multiplex ligation dependent probe amplification.EXCLI J2016https://conductscience.org/library/papers/27065772PubMed
26987530Epigenetic Biomarkers of Breast Cancer Risk: Across the Breast Cancer Prevention Continuum.Adv Exp Med Biol2016https://conductscience.org/library/papers/26987530PubMed
26585467Aberrant GSTP1 promoter methylation is associated with increased risk and advanced stage of breast cancer: a meta-analysis of 19 case-control studies.BMC Cancer2015https://conductscience.org/library/papers/26585467PubMed
26510686Exploring DNA methylation changes in promoter, intragenic, and intergenic regions as early and late events in breast cancer formation.BMC Cancer2015https://conductscience.org/library/papers/26510686PubMed
26425077Clinicopathological significance and potential drug target of CDH1 in breast cancer: a meta-analysis and literature review.Drug Des Devel Ther2015https://conductscience.org/library/papers/26425077PubMed
25155055BRCA1 promoter methylation of normal breast epithelial cells as a possible precursor for BRCA1-methylated breast cancer.Cancer Sci2014https://conductscience.org/library/papers/25155055PubMed

See all 41 cited byDownload CSV of cited by

Genes14

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19789364

GET https://conductscience.org/api/papers/v1/19789364/authors?page=2